【#イベルメクチン】米国でもイベルメクチンの外来販売量上昇中なので厚労省も焦ってるかも😅
米国でもイベルメクチンの外来販売量上昇中なので厚労省も焦ってるかも😅
— c-trichoides (@OhyamaTochiro) February 21, 2021
Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemichttps://t.co/wqJrtzGYi3 pic.twitter.com/8bgBjiVKuj